搜尋結果
2023
Narwanti, I. ,
Yu, Z. Y. ,
Sethy, B. ,
Lai, M. J. ,
Lee, H. Y. ,
Olena, P. ,
Lee, S. B. &
Liou, J. P. ,
10月 2023 ,
於: European Journal of Medicinal Chemistry. 258 , 115505.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Dephosphorylation
100%
Apoptotic
91%
Antiproliferative
79%
Quinone
75%
Colorectal Neoplasms
63%
Tseng, H. J. ,
Banerjee, S. ,
Qian, B. ,
Lai, M. J. ,
Wu, T. Y. ,
Hsu, T. I. ,
Lin, T. E. ,
Hsu, K. C. ,
Chuang, K. H. ,
Liou, J. P. &
Shih, J. C. ,
8月 2023 ,
於: European Journal of Medicinal Chemistry. 256 , 115459.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Dual Oxidases
100%
Hsp90 Inhibitor
96%
HSP90 Heat-Shock Proteins
79%
Monoamine Oxidase
70%
Monoamine
69%
Wu, T. Y. ,
Chen, M. ,
Chen, I. C. ,
Chen, Y. J. ,
Chen, C. Y. ,
Wang, C. H. ,
Cheng, J. J. ,
Nepali, K. ,
Chuang, K. H. &
Liou, J. P. ,
4月 2023 ,
於: Journal of Advanced Research. 46 ,
p. 159-171 研究成果: 雜誌貢獻 › 文章 › 同行評審
Growth Inhibition
100%
Addition Compound
51%
Effector
45%
Antineoplastic Agent
37%
Drug
22%
Nepali, K. ,
Wu, A. C. ,
Lo, W. L. ,
Chopra, B. ,
Lai, M. J. ,
Chuang, J. Y. &
Liou, J. P. ,
2月 2023 ,
於: European Journal of Medicinal Chemistry. 248 , 115054.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Donepezil
100%
Anti Alzheimer
96%
Hydroxamic Acid
79%
Glioblastoma
64%
Agonist
62%
2022
Wang, Y. S. ,
Yeh, T. K. ,
Chang, W. C. ,
Liou, J. P. ,
Liu, Y. M. &
Huang, W. C. ,
12月 5 2022 ,
於: European Journal of Medicinal Chemistry. 243 , 114773.
研究成果: 雜誌貢獻 › 文章 › 同行評審
2,6-difluorobenzamide
100%
Calcium Channels
45%
2-aminoethoxydiphenyl borate
9%
Colorectal Neoplasms
9%
Dose
9%
Sharma, R. ,
Chatterjee, E. ,
Mathew, J. ,
Sharma, S. ,
Rao, N. V. ,
Pan, C. H. ,
Lee, S. B. ,
Dhingra, A. ,
Grewal, A. S. ,
Liou, J. P. ,
Guru, S. K. &
Nepali, K. ,
10月 5 2022 ,
於: European Journal of Medicinal Chemistry. 240 , 114602.
研究成果: 雜誌貢獻 › 文章 › 同行評審
2,3-trimethylene-4-quinazolone
100%
Deoxyvasicinone
76%
Nanocarrier
44%
Inhibitory Concentration 50
37%
Quinazolinones
36%
Yeh, L-Y. ,
Fang, Y-T. ,
Lee, H-S. ,
Liu, C-H. ,
Chen, Y-Y. ,
Lo, Y-C. ,
Laiman, V. ,
Liou, J-P. ,
Chung, K. F. ,
Chuang, H-C. &
Lin, C-H. ,
5月 2022 ,
於: Frontiers in Medicine. 9 , 794025.
研究成果: 雜誌貢獻 › 文章 › 同行評審
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
100%
Histone Deacetylase Inhibitors
49%
Emphysema
47%
Body Weight
22%
Pancreatic Elastase
9%
Wu, A. C. ,
Yang, W. B. ,
Chang, K. Y. ,
Lee, J. S. ,
Liou, J. P. ,
Su, R. Y. ,
Cheng, S. M. ,
Hwang, D. Y. ,
Kikkawa, U. ,
Hsu, T. I. ,
Wang, C. Y. ,
Chang, W. C. ,
Chen, P. Y. &
Chuang, J. Y. ,
12月 2022 ,
於: Journal of Experimental and Clinical Cancer Research. 41 ,
1 , 47.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Long Noncoding RNA
100%
Glioblastoma
91%
MicroRNAs
77%
Cell Proliferation
60%
Messenger RNA
52%
Mehndiratta, S. ,
Qian, B. ,
Chuang, J. Y. ,
Liou, J. P. &
Shih, J. C. ,
2月 2022 ,
於: Journal of Medicinal Chemistry. 65 ,
3 ,
p. 2208-2224 17 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hydroxamic Acids
100%
Hydroxamic Acid
74%
Monoamine Oxidase
72%
Histone Deacetylases
72%
Monoamine
71%
Li, J. ,
Hsiung, S. Y. ,
Kao, M. R. ,
Xing, X. ,
Chang, S. C. ,
Wang, D. ,
Hsieh, P. Y. ,
Liang, P. H. ,
Zhu, Z. ,
Cheng, T. J. R. ,
Shie, J. J. ,
Liou, J. P. ,
Abbott, D. W. ,
Kwon, S. W. &
Hsieh, Y. S. Y. ,
11月 2022 ,
於: Carbohydrate Research. 521 , 108662.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Polygonatum
100%
Rhizome
72%
Cell Wall
56%
Polysaccharides
52%
Polysaccharide
47%
2021
Wu, Y. W. ,
Chao, M. W. ,
Tu, H. J. ,
Chen, L. C. ,
Hsu, K. C. ,
Liou, J. P. ,
Yang, C. R. ,
Yen, S. C. ,
HuangFu, W. C. &
Pan, S. L. ,
5月 2021 ,
於: Oncogenesis. 10 ,
5 , 39.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase Inhibitors
100%
Leukemia
69%
Down-Regulation
59%
In Vitro Techniques
37%
Mitogen-Activated Protein Kinase Kinases
23%
Chang, T. Y. ,
Nepali, K. ,
Chen, Y. Y. ,
Yang, Y. C. S. H. ,
Hsu, K. C. ,
Yen, Y. ,
Pan, S. L. ,
Liou, J. P. &
Lee, S. B. ,
6月 2021 ,
於: Biomedicine and Pharmacotherapy. 138 , 111485.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase Inhibitors
100%
Histone Deacetylases
99%
Cell Cycle Checkpoints
83%
Mitosis
28%
Epigenomics
24%
Singh, A. ,
Chang, T. Y. ,
Kaur, N. ,
Hsu, K. C. ,
Yen, Y. ,
Lin, T. E. ,
Lai, M. J. ,
Lee, S. B. &
Liou, J. P. ,
4月 5 2021 ,
於: European Journal of Medicinal Chemistry. 215 , 113169.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chidamide
100%
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
90%
Anilides
85%
entinostat
77%
Anilide
61%
Hsieh, T. H. ,
Liang, M. L. ,
Zheng, J. H. ,
Lin, Y. C. ,
Yang, Y. C. S. H. ,
Vo, T. H. ,
Liou, J. P. ,
Yen, Y. &
Chen, C. H. ,
12月 1 2021 ,
於: Cancers. 13 ,
23 , 6117.
研究成果: 雜誌貢獻 › 文章 › 同行評審
MPT0L145
100%
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine
74%
Glioblastoma
40%
Autophagy
39%
Cell Proliferation
16%
Mehndiratta, S. ,
Chen, M. C. ,
Chao, Y. H. ,
Lee, C. H. ,
Liou, J. P. ,
Lai, M. J. &
Lee, H. Y. ,
1月 1 2021 ,
於: Journal of Enzyme Inhibition and Medicinal Chemistry. 36 ,
1 ,
p. 74-84 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylases
100%
Apoptotic
98%
A549 Cells
94%
Histone
91%
Antiproliferative
85%
Huang, H. L. ,
Liu, Y. M. ,
Sung, T. Y. ,
Huang, T. C. ,
Cheng, Y. W. ,
Liou, J. P. &
Pan, S. L. ,
1月 1 2021 ,
於: Theranostics. 11 ,
5 ,
p. 2079 1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Colorectal Neoplasms
100%
Neoplasm Metastasis
77%
Growth
63%
Neoplasms
40%
Yang, W. B. ,
Wu, A. C. ,
Hsu, T. I. ,
Liou, J. P. ,
Lo, W. L. ,
Chang, K. Y. ,
Chen, P. Y. ,
Kikkawa, U. ,
Yang, S. T. ,
Kao, T. J. ,
Chen, R. M. ,
Chang, W. C. ,
Ko, C. Y. &
Chuang, J. Y. ,
10月 2021 ,
於: Cell Death and Disease. 12 ,
10 , 884.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase 6
100%
Glioblastoma
60%
DNA Repair
57%
DNA Damage
53%
Cell Survival
46%
Ojha, R. ,
Chen, I. C. ,
Hsieh, C. M. ,
Nepali, K. ,
Lai, R. W. ,
Hsu, K. C. ,
Lin, T. E. ,
Pan, S. L. ,
Chen, M. C. &
Liou, J. P. ,
2021 , (接受/付印)
於: Journal of Medicinal Chemistry. 64 ,
24 ,
p. 17824-17845 22 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pargyline
100%
Hydroxamic Acid
76%
Histone Deacetylase Inhibitors
73%
Antiproliferative
62%
Bioavailability
61%
Putri, A. D. ,
Chen, P. S. ,
Su, Y. L. ,
Lin, J. P. ,
Liou, J. P. &
Hsieh, C. M. ,
10月 2021 ,
於: Pharmaceutics. 13 ,
10 , 1728.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase Inhibitors
100%
Histone
91%
Human Serum Albumin
80%
Nanoparticles
75%
Albumins
73%
Nepali, K. ,
Hsu, T. I. ,
Hsieh, C. M. ,
Lo, W. L. ,
Lai, M. J. ,
Hsu, K. C. ,
Lin, T. E. ,
Chuang, J. Y. &
Liou, J. P. ,
5月 5 2021 ,
於: European Journal of Medicinal Chemistry. 217 , 113338.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Memantine
100%
Histone Deacetylase Inhibitors
70%
Glioblastoma
59%
Hydroxamic Acid
48%
Permeability
48%
Liu, Y. M. ,
Tu, H. J. ,
Wu, C. H. ,
Lai, M. J. ,
Yu, S. C. ,
Chao, M. W. ,
Wu, Y. W. ,
Teng, C. M. ,
Pan, S. L. &
Liou, J. P. ,
7月 5 2021 ,
於: European Journal of Medicinal Chemistry. 219 , 113428.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Benzamides
100%
50 Percent Growth Inhibition
80%
Inhibitory Concentration 50
53%
Ring Opening Reaction
52%
Lung Neoplasms
35%
Wang, C. A. ,
Li, C. F. ,
Huang, R. C. ,
Li, Y. H. ,
Liou, J. P. &
Tsai, S. J. ,
9月 2021 ,
於: Molecular Cancer Therapeutics. 20 ,
9 ,
p. 1550-1560 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Vascular Endothelial Growth Factor C
100%
Lymphangiogenesis
99%
Extracellular Vesicles
86%
Dual Specificity Phosphatase 2
84%
Pancreatic Neoplasms
69%
2020
Lin, Y. C. ,
Chen, M. C. ,
Hsieh, T. H. ,
Liou, J. P. &
Chen, C. H. ,
4月 15 2020 ,
於: Aging. 12 ,
7 ,
p. 5764-5780 17 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Urinary Bladder Neoplasms
100%
PF-670462
22%
erdafitinib
21%
Pyrrolo(2,3-d)pyrimidine
20%
Therapeutics
17%
Wu, W. C. ,
Liu, Y. M. ,
Lin, M. H. ,
Liao, Y. H. ,
Lai, M. J. ,
Chuang, H. Y. ,
Hung, T. Y. ,
Chen, C. H. &
Liou, J. P. ,
4月 15 2020 ,
於: European Journal of Medicinal Chemistry. 192 ,
p. 112158 112158.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Benzamides
100%
Vincristine
58%
Microtubules
57%
Etoposide
54%
Resistance
37%
Wu, W. C. ,
Liu, Y. M. ,
Liao, Y. H. ,
Hsu, K. C. ,
Lien, S. T. ,
Chen, I. C. ,
Lai, M. J. ,
Li, Y. H. ,
Pan, S. L. ,
Chen, M. C. &
Liou, J. P. ,
10月 1 2020 ,
於: European Journal of Medicinal Chemistry. 203 , 112540.
研究成果: 雜誌貢獻 › 文章 › 同行評審
HSP90 Heat-Shock Proteins
100%
Antineoplastic Agents
72%
Non-Small Cell Lung Carcinoma
67%
Antineoplastic Agent
67%
Colorectal Neoplasms
60%
Fang, Y-C. ,
Chan, L. ,
Liou, J-P. ,
Tu, Y-K. ,
Lai, M-J. ,
Chen, C-I. ,
Vidyanti, A. N. ,
Lee, H-Y. &
Hu, C-J. ,
6月 1 2020 ,
於: Journal of Cellular and Molecular Medicine. 24 ,
12 ,
p. 6966-6977 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase Inhibitors
100%
Brain-Derived Neurotrophic Factor
90%
Acetylation
89%
Histones
64%
Oxygen
60%
Buyandelger, B. ,
Bar, E. E. ,
Hung, K. S. ,
Chen, R. M. ,
Chiang, Y. H. ,
Liou, J. P. ,
Huang, H. M. &
Wang, J. Y. ,
2020 ,
於: International Journal of Biological Sciences. 16 ,
16 ,
p. 3184-3199 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
histone deacetylase
100%
glioma
94%
Histone Deacetylase Inhibitors
84%
acetylation
78%
Acetylation
76%
Yang, W-B. ,
Hsu, C-C. ,
Hsu, T-I. ,
Liou, J-P. ,
Chang, K-Y. ,
Chen, P-Y. ,
Liu, J-J. ,
Yang, S-T. ,
Wang, J-Y. ,
Yeh, S-H. ,
Chen, R-M. ,
Chang, W-C. &
Chuang, J-Y. ,
10月 1 2020 ,
於: Neuro-Oncology. 22 ,
10 ,
p. 1439-1451 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Glioblastoma
100%
Temozolomide
71%
Growth
51%
Proteins
37%
Histone Deacetylases
33%
Ojha, R. ,
Nepali, K. ,
Chen, C. H. ,
Chuang, K. H. ,
Wu, T. Y. ,
Lin, T. E. ,
Hsu, K. C. ,
Chao, M. W. ,
Lai, M. J. ,
Lin, M. H. ,
Huang, H. L. ,
Chang, C. D. ,
Pan, S. L. ,
Chen, M. C. &
Liou, J. P. ,
3月 15 2020 ,
於: European Journal of Medicinal Chemistry. 190 , 112086.
研究成果: 雜誌貢獻 › 文章 › 同行評審
50 Percent Growth Inhibition
100%
compound 17
97%
Lung Neoplasms
58%
Inhibitory Concentration 50
53%
Lung
39%
Mehndiratta, S. ,
Lin, M. H. ,
Wu, Y. W. ,
Chen, C. H. ,
Wu, T. Y. ,
Chuang, K. H. ,
Chao, M. W. ,
Chen, Y. Y. ,
Pan, S. L. ,
Chen, M. C. &
Liou, J. P. ,
1月 1 2020 ,
於: European Journal of Medicinal Chemistry. 185 ,
p. 111725 111725.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Anilides
100%
HSP90 Heat-Shock Proteins
73%
Anilide
72%
Histone Deacetylase Inhibitors
65%
Histone
59%
Kaur, N. ,
Fang, Y. C. ,
Lee, H. Y. ,
Singh, A. ,
Nepali, K. ,
Lin, M. H. ,
Yeh, T. K. ,
Lai, M. J. ,
Chan, L. ,
Tu, Y. K. ,
Banerjee, S. ,
Hu, C. J. &
Liou, J. P. ,
2月 1 2020 ,
於: European Journal of Medicinal Chemistry. 187 , 111915.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Azepines
100%
Azepine
76%
Histone
60%
Protective
46%
Cognitive Dysfunction
46%
Nepali, K. ,
Chang, T. Y. ,
Lai, M. J. ,
Hsu, K. C. ,
Yen, Y. ,
Lin, T. E. ,
Lee, S. B. &
Liou, J. P. ,
6月 15 2020 ,
於: European Journal of Medicinal Chemistry. 196 , 112291.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chidamide
95%
Benzamide
80%
Histone Deacetylase Inhibitors
79%
purine
78%
Histone
73%
Wang, S. W. ,
Lin, M. H. ,
Hsu, F. C. ,
Chen, M. C. ,
Liou, J. P. ,
Liu, Y. T. ,
Chen, S. S. &
Lee, H. Y. ,
2月 1 2020 ,
於: Bioorganic and Medicinal Chemistry. 28 ,
3 ,
p. 115250 115250.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Antiproliferative
100%
Protein Isoforms
80%
HCT116 Cells
64%
Ether
55%
A549 Cells
55%
2019
Lai, M. J. ,
Ojha, R. ,
Lin, M. H. ,
Liu, Y. M. ,
Lee, H. Y. ,
Lin, T. E. ,
Hsu, K. C. ,
Chang, C. Y. ,
Chen, M. C. ,
Nepali, K. ,
Chang, J. Y. &
Liou, J. P. ,
1月 15 2019 ,
於: European Journal of Medicinal Chemistry. 162 ,
p. 612-630 19 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
indoline
100%
Benzamides
91%
Histone Deacetylases
63%
Tubulin
58%
Histone
58%
Nepali, K. ,
Lin, M. H. ,
Chao, M. W. ,
Peng, S. J. ,
Hsu, K. C. ,
Eight Lin, T. ,
Chen, M. C. ,
Lai, M. J. ,
Pan, S. L. &
Liou, J. P. ,
10月 1 2019 ,
於: Bioorganic Chemistry. 91 , 103119.
研究成果: 雜誌貢獻 › 文章 › 同行評審
resorcinol
100%
quinoline
91%
Growth Inhibitors
83%
PC-3 Cells
78%
Amides
75%
Hsieh, Y. L. ,
Tu, H. J. ,
Pan, S. L. ,
Liou, J. P. &
Yang, C. R. ,
6月 1 2019 ,
於: Biochimica et Biophysica Acta - Molecular Cell Research. 1866 ,
6 ,
p. 992-1003 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase 6
100%
Triple Negative Breast Neoplasms
74%
Histone Deacetylase Inhibitors
72%
Breast Neoplasms
39%
Acetylation
27%
Chao, M. W. ,
Chang, L. H. ,
Tu, H. J. ,
Chang, C. D. ,
Lai, M. J. ,
Chen, Y. Y. ,
Liou, J. P. ,
Teng, C. M. &
Pan, S. L. ,
5月 29 2019 ,
於: Clinical Epigenetics. 11 ,
1 ,
p. 85 85.
研究成果: 雜誌貢獻 › 文章 › 同行評審
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
100%
Histone Deacetylase Inhibitors
49%
Mitogen-Activated Protein Kinase Kinases
46%
Pancreatic Neoplasms
40%
ErbB Receptors
13%
Huang, F. I. ,
Wu, Y. W. ,
Sung, T. Y. ,
Liou, J. P. ,
Lin, M. H. ,
Pan, S. L. &
Yang, C. R. ,
1月 1 2019 ,
於: Frontiers in Oncology. 9 ,
APR ,
p. 249 249.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase 6
100%
Bortezomib
75%
Multiple Myeloma
61%
Histone Deacetylase Inhibitors
20%
Neoplasms
19%
Chen, M. C. ,
Lin, Y. C. ,
Liao, Y. H. ,
Liou, J. P. &
Chen, C. H. ,
10月 2019 ,
於: Cancers. 11 ,
10 , 1617.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Colorectal Neoplasms
100%
Ligands
88%
Apoptosis
76%
Autophagy
72%
Cell Death
57%
Pyrrolo(2,3-d)pyrimidine
100%
Ring Formation
53%
Antineoplastic Agents
49%
Urinary Bladder Neoplasms
49%
Pyrimidine
45%
Chen, C. H. ,
Hsieh, T. H. ,
Lin, Y. C. ,
Liu, Y. R. ,
Liou, J. P. &
Yen, Y. ,
9月 2019 ,
於: Cancers. 11 ,
9 , 1345.
研究成果: 雜誌貢獻 › 文章 › 同行評審
MPT0L145
100%
Autophagy
39%
Fibroblast Growth Factor Receptors
35%
Drug Combinations
14%
Neoplasms
13%
Huang, H. L. ,
Liu, Y. M. ,
Sung, T. Y. ,
Huang, T. C. ,
Cheng, Y. W. ,
Liou, J. P. &
Pan, S. L. ,
1月 1 2019 ,
於: Theranostics. 9 ,
22 ,
p. 6676-6689 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tissue Inhibitor of Metalloproteinase-3
100%
Colorectal Neoplasms
53%
Neoplasm Metastasis
41%
Growth
34%
Neoplasms
21%
2018
Lee, H. Y. ,
Nepali, K. ,
Huang, F. I. ,
Chang, C. Y. ,
Lai, M. J. ,
Li, Y. H. ,
Huang, H. L. ,
Yang, C. R. &
Liou, J. P. ,
2月 8 2018 ,
於: Journal of Medicinal Chemistry. 61 ,
3 ,
p. 905-917 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Quinolines
100%
Histone Deacetylase 6
94%
Histone Deacetylase Inhibitors
68%
Histone
62%
Multiple Myeloma
57%
Ojha, R. ,
Huang, H. L. ,
HuangFu, W. C. ,
Wu, Y. W. ,
Nepali, K. ,
Lai, M. J. ,
Su, C. J. ,
Sung, T. Y. ,
Chen, Y. L. ,
Pan, S. L. &
Liou, J. P. ,
4月 25 2018 ,
於: European Journal of Medicinal Chemistry. 150 ,
p. 667-677 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hydroxamic Acids
100%
50 Percent Growth Inhibition
83%
Histone Deacetylase Inhibitors
72%
Antineoplastic Agents
59%
Antineoplastic Agent
54%
Lee, H. Y. ,
Fan, S. J. ,
Huang, F. I. ,
Chao, H. Y. ,
Hsu, K. C. ,
Lin, T. E. ,
Yeh, T. K. ,
Lai, M. J. ,
Li, Y. H. ,
Huang, H. L. ,
Yang, C. R. &
Liou, J. P. ,
8月 23 2018 ,
於: Journal of Medicinal Chemistry. 61 ,
16 ,
p. 7087-7102 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase 6
100%
tau Proteins
77%
Histone Deacetylase Inhibitors
72%
Histone
66%
Hydroxamic Acids
49%
Wu, Y. W. ,
Hsu, K. C. ,
Lee, H. Y. ,
Huang, T. C. ,
Lin, T. E. ,
Chen, Y. L. ,
Sung, T. Y. ,
Liou, J. P. ,
Hwang-Verslues, W. W. ,
Pan, S. L. &
HuangFu, W. C. ,
3月 13 2018 ,
於: Frontiers in Pharmacology. 9 ,
MAR , 205.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Tubulin Modulators
100%
In Vitro Techniques
26%
Tubulin
26%
Histone Deacetylase 6
19%
Neoplasms
19%
Nepali, K. ,
Kumar, S. ,
Huang, H. L. ,
Kuo, F. C. ,
Lee, C. H. ,
Kuo, C. C. ,
Yeh, T. K. ,
Li, Y. H. ,
Chang, J. Y. ,
Liou, J. P. &
Lee, H. Y. ,
1月 1 2018 ,
於: Organic and Biomolecular Chemistry. 16 ,
25 ,
p. 4734 1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dione
100%
HSP90 Heat-Shock Proteins
86%
Tubulin
70%
Antineoplastic Agents
62%
Antineoplastic Agent
58%
Chen, C. H. ,
Changou, C. A. ,
Hsieh, T. H. ,
Lee, Y. C. ,
Chu, C. Y. ,
Hsu, K. C. ,
Wang, H. C. ,
Lin, Y. C. ,
Lo, Y. N. ,
Liu, Y. R. ,
Liou, J. P. &
Yen, Y. ,
3月 1 2018 ,
於: Clinical Cancer Research. 24 ,
5 ,
p. 1176-1189 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
MPT0L145
100%
Urinary Bladder Neoplasms
39%
Autophagy
21%
Cell Death
13%
Smegmamorpha
6%
Tsai, I. T. ,
Kuo, C. C. ,
Liou, J. P. &
Chang, J. Y. ,
3月 28 2018 ,
於: Journal of Biomedical Science. 25 ,
1 ,
p. 28 28.
研究成果: 雜誌貢獻 › 文章 › 同行評審
MPT0B098
100%
Squamous Cell Carcinoma of Head and Neck
45%
Epithelial-Mesenchymal Transition
42%
Microtubules
39%
Hypoxia
32%
Tu, H. J. ,
Lin, Y. J. ,
Chao, M. W. ,
Sung, T. Y. ,
Wu, Y. W. ,
Chen, Y. Y. ,
Lin, M. H. ,
Liou, J. P. ,
Pan, S. L. &
Yang, C. R. ,
12月 29 2018 ,
於: Clinical Epigenetics. 10 ,
1 , 162.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Leukemia
100%
Vincristine
75%
Histone Deacetylase 6
56%
Doxorubicin
48%
Drug Therapy
30%